... if our technology proves 100 % to be the real deal , then Edward's Biosciences absolutely must acquire or partner us ...
Their $US 53 Billion market cap requires them to maintain their market share , or to expand it ... AVR is both those things to them ... EB only has $ 5.2 B. in annual revenue .... even so , they extract a healthy $ 1.5 B. profit from that ...
... other medical companies may eventually want us , but Edward's simply must have us ... sooner or later ...
Webinar video link - must watch, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.06 |
Change
-0.140(1.37%) |
Mkt cap ! $221.9M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.50 | $10.06 | $43.02K | 4.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $10.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.13 | 332 | 3 |
View Market Depth
| Last trade - 12.05pm 04/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |